T1	Participants 35 122	blood coagulation in patients with coronary artery disease following 28 days of therapy
T2	Participants 247 289	patients with coronary artery disease (CAD
T3	Participants 382 399	26 males with CAD
T4	Participants 1509 1540	myocardial infarction or stroke
